CORONA, CA – November 10, 2025 – PRESSADVANTAGE – Moment of Clarity has published a new resource, “TMS Therapy Success Rate ...

A new $5.2 million grant from the Washington Research Foundation will help develop a new clinical trials program between Fred ...

The treatment landscape for systemic lupus erythematosus (SLE) has shifted greatly in recent years, driven by the emergence of cell-based immunotherapies targeting pathogenic B-cell populations. Among ...

NV-387 Could be the Answer to the MPox Clade I Rising in the USA, Says Dr. Diwan SHELTON, CONNECTICUT / ACCESS Newswire / November 5, 2025 / NanoViricides, Inc. (NYSE American:NNVC ) (the “Company”), ...

Breast cancer advancements include targeted therapies, oral medications for ER-positive/HER2-negative populations, and ...

A new peer-reviewed study published in Nature Scientific Reports reveals that large language models (LLMs) often overlook key clinical nuances when handling complex medical queries, raising questions ...

F32 grants from the National Institutes of Health (NIH) help early-career physician-scientists launch research careers, ...

Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose ...

Experiments with genetically engineered mice suggest that breaking up the protein partnership could be an effective strategy.

A study published Wednesday reports "significant" disparities in the risk of dementia for lower income and non-white ...

Experts say FDA officials and doctors should treat hormone therapy like any other drug that has both benefits and risks, and remember that hormones aren’t the only options for treating menopausal ...

Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose ...